Unprecedented Early-Stage Cancer Detection Presented at AACR 2026
Dxcover, a global leader in AI-enabled technologies, today announced the presentation of multiple studies at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California this month.
Dxcover Secures CE-IVDR Certification
Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746.
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Dxcover, a clinical-stage oncology diagnostics company developing and commercializing its Multiomic Spectral Analysis platform (MOSA-Dx™), today announced the strategic expansion of its Scientific Advisory Board (SAB) and Board of Directors. These appointments bring world-class expertise across neurology, gynaecological and pancreatic oncology, clinical statistics, artificial intelligence, and commercial diagnostics - strengthening Dxcover’s position as it enters its next phase of clinical translation and commercial growth.
